{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:36:25Z","timestamp":1762508185189,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"vor","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016036","name":"Health~Holland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016036","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["phiro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physics and Imaging in Radiation Oncology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.phro.2020.07.006","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T06:55:05Z","timestamp":1596783305000},"page":"60-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Focal salvage treatment for radiorecurrent prostate cancer: A magnetic resonance-guided stereotactic body radiotherapy versus high-dose-rate brachytherapy planning study"],"prefix":"10.1016","volume":"15","author":[{"given":"Thomas","family":"Willigenburg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellis","family":"Beld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochem","family":"Hes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan J.W.","family":"Lagendijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans C.J.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marinus A.","family":"Moerland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochem R.N.","family":"van der Voort van Zyp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phro.2020.07.006_b0005","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.radonc.2013.09.026","article-title":"Long-term results of the Dutch randomized prostate cancer trial: Impact of dose-escalation on local, biochemical, clinical failure, and survival","volume":"110","author":"Heemsbergen","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2020.07.006_b0010","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ijrobp.2010.03.049","article-title":"70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial","volume":"80","author":"Beckendorf","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2020.07.006_b0015","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.juro.2015.06.100","article-title":"Anatomic Patterns of Recurrence Following Biochemical Relapse in the Dose-Escalation Era for Prostate Patients Undergoing External Beam Radiotherapy","volume":"194","author":"Zumsteg","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.phro.2020.07.006_b0020","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1177\/1533034617741797","article-title":"Focal MRI-Guided Salvage High-Dose-Rate Brachytherapy in Patients With Radiorecurrent Prostate Cancer","volume":"16","author":"Maenhout","year":"2017","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.phro.2020.07.006_b0025","first-page":"582","article-title":"A review of salvage treatment options for disease progression after radiation therapy for localized prostate cancer","volume":"37","author":"Steele","year":"2019","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"10.1016\/j.phro.2020.07.006_b0030","doi-asserted-by":"crossref","first-page":"L41","DOI":"10.1088\/1361-6560\/aa9517","article-title":"First patients treated with a 1.5 T MRI-Linac: clinical proof of concept of a high-precision, high-field MRI guided radiotherapy treatment","volume":"62","author":"Raaymakers","year":"2017","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.phro.2020.07.006_b0035","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.semradonc.2014.02.009","article-title":"The Magnetic Resonance Imaging-Linac System","volume":"24","author":"Lagendijk","year":"2014","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.phro.2020.07.006_b0040","doi-asserted-by":"crossref","unstructured":"de Muinck Keizer DM, Pathmanathan AU, Andreychenko A, Kerkmeijer LGW, van der Voort van Zyp JRN, Tree AC, et al. Fiducial marker based intra-fraction motion assessment on cine-MR for MR-Linac treatment of prostate cancer. Phys Med Biol 2019;64:07NT02. https:\/\/doi.org\/10.1088\/1361-6560\/ab09a6.","DOI":"10.1088\/1361-6560\/ab09a6"},{"key":"10.1016\/j.phro.2020.07.006_b0045","doi-asserted-by":"crossref","first-page":"7485","DOI":"10.1088\/0031-9155\/60\/19\/7485","article-title":"A new methodology for inter- and intrafraction plan adaptation for the MR-linac","volume":"60","author":"Kontaxis","year":"2015","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.phro.2020.07.006_b0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cmpb.2009.04.008","article-title":"Simultaneous multi-modality ROI delineation in clinical practice","volume":"96","author":"Bol","year":"2009","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.phro.2020.07.006_b0055","doi-asserted-by":"crossref","unstructured":"de Muinck Keizer DM, Kerkmeijer LGW, Maspero M, Andreychenko A, van der Voort van Zyp JRN, van den Berg CAT, et al. Soft-tissue prostate intrafraction motion tracking in 3D cine-MR for MR-guided radiotherapy. Phys Med Biol 2019;64:235008. https:\/\/doi.org\/10.1088\/1361-6560\/ab5539.","DOI":"10.1088\/1361-6560\/ab5539"},{"key":"10.1016\/j.phro.2020.07.006_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2020.06.044","article-title":"Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions","author":"de Muinck Keizer","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2020.07.006_b0065","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1088\/1361-6560\/aa82ae","article-title":"Towards fast online intrafraction replanning for free-breathing stereotactic body radiation therapy with the MR-linac","volume":"62","author":"Kontaxis","year":"2017","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.phro.2020.07.006_b0070","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ab7630","article-title":"DeepDose: towards a fast dose calculation engine for radiation therapy using deep learning","volume":"65","author":"Kontaxis","year":"2020","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.phro.2020.07.006_b0075","doi-asserted-by":"crossref","unstructured":"Woodings SJ, Bluemink JJ, de Vries JHW, Niatsetski Y, van Veelen B, Schillings J, et al. Beam characterisation of the 1.5 T MRI-linac. Phys Med Biol 2018;63:085015. https:\/\/doi.org\/10.1088\/1361-6560\/aab566.","DOI":"10.1088\/1361-6560\/aab566"},{"key":"10.1016\/j.phro.2020.07.006_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2016.11.018","article-title":"Single Fraction External Beam Radiotherapy for Localised Prostate Cancer: a Planning Study","volume":"29","author":"Henderson","year":"2017","journal-title":"Clin Oncol"},{"key":"10.1016\/j.phro.2020.07.006_b0085","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13014-018-1112-0","article-title":"ONE SHOT - single shot radiotherapy for localized prostate cancer: Study protocol of a single arm, multicenter phase I\/II trial","volume":"13","author":"Zilli","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2020.07.006_b0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.radonc.2019.07.018","article-title":"Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial","volume":"139","author":"Zilli","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2020.07.006_b0095","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijrobp.2020.01.023","article-title":"MRI-Guided Ultrafocal Salvage High-Dose-Rate Brachytherapy for Localized Radiorecurrent Prostate Cancer: Updated Results of 50 Patients","volume":"107","author":"van Son","year":"2020","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.phro.2020.07.006_b0100","doi-asserted-by":"crossref","unstructured":"Van Son M, Peters M, Moerland M, Kerkmeijer L, Lagendijk J, Van der Voort van Zyp J. Focal salvage treatment of radiorecurrent prostate cancer: A narrative review of current strategies and future perspectives. Cancers (Basel) 2018;10:480. https:\/\/doi.org\/10.3390\/cancers10120480.","DOI":"10.3390\/cancers10120480"},{"key":"10.1016\/j.phro.2020.07.006_b0105","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ijrobp.2018.06.039","article-title":"Focal Salvage High Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer After Primary Radiation Therapy Failure: Results From a Prospective Clinical Trial","volume":"102","author":"Murgic","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2020.07.006_b0110","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13014-018-1112-0","article-title":"ONE SHOT - single shot radiotherapy for localized prostate cancer: Study protocol of a single arm, multicenter phase I\/II trial","volume":"13","author":"Zilli","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2020.07.006_b0115","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial","volume":"394","author":"Widmark","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.phro.2020.07.006_b0120","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.radonc.2015.12.020","article-title":"Dose-escalation of five-fraction SABR in prostate cancer: Toxicity comparison of two prospective trials","volume":"118","author":"Musunuru","year":"2016","journal-title":"Radiother Oncol"}],"container-title":["Physics and Imaging in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631620300415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631620300415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:13:19Z","timestamp":1762503199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405631620300415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":24,"alternative-id":["S2405631620300415"],"URL":"https:\/\/doi.org\/10.1016\/j.phro.2020.07.006","relation":{},"ISSN":["2405-6316"],"issn-type":[{"type":"print","value":"2405-6316"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Focal salvage treatment for radiorecurrent prostate cancer: A magnetic resonance-guided stereotactic body radiotherapy versus high-dose-rate brachytherapy planning study","name":"articletitle","label":"Article Title"},{"value":"Physics and Imaging in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phro.2020.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}]}}